The prognostic value of androgen receptor expression in triple-negative breast cancer patients

被引：0
|
作者：
Haggag, R. M. [1 ]
Abu-Taleb, F. M. [1 ]
Elsayed, H. [2 ]
Shiha, A. [3 ]
机构：
[1] Zagazig Univ, Fac Med, Dept Med Oncol, Zagazig, Egypt
[2] Mil Acad, Maadi Armed Forces Med Complex, Dept Histopathol, Cairo, Egypt
[3] Mil Acad, Maadi Armed Forces Med Complex, Dept Med Oncol, Cairo, Egypt
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16P
引用
收藏
页码：S1436 / S1436
页数：1
相关论文
共 50 条
  • [21] Androgen Receptor Immunoexpression in Triple-Negative Breast Cancer
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    MODERN PATHOLOGY, 2015, 28 : 33A - 34A
  • [22] PROGNOSTIC SIGNIFICANCE OF ANDROGEN RECEPTOR EXPRESSION IN HER2-POSITIVE AND TRIPLE-NEGATIVE BREAST CANCER
    Kucukzeybek, Betul Bolat
    Bayoglu, Ibrahim V.
    Kucukzeybek, Yuksel
    Yildiz, Yasar
    Oflazoglu, Utku
    Atahan, Murat K.
    Taskaynatan, Halil
    Alacacioglu, Ahmet
    Yigit, Seyran
    Tarhan, Mustafa O.
    POLISH JOURNAL OF PATHOLOGY, 2018, 69 (02) : 157 - 168
  • [23] Role of undifferentiation markers and androgen receptor expression in triple-negative breast cancer
    Castaneda, Carlos A.
    Castillo, Miluska
    Enciso, Javier A.
    Enciso, Nathaly
    Bernabe, Luis A.
    Sanchez, Joselyn
    Guerra, Henry
    Chavez, Carlos
    Landa-Baella, Maria
    De-La-Cruz, Miguel
    Villa-Robles, Maria
    Tello, Katherine
    Gomez, Henry L.
    BREAST JOURNAL, 2019, 25 (06): : 1316 - 1319
  • [24] Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer
    Di Leone, A.
    Fragomeni, S. M.
    Scardina, L.
    Ionta, L.
    Mule, A.
    Magno, S.
    Terribile, D.
    Masetti, R.
    Franceschini, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1910 - 1915
  • [25] Prognostic value of androgen receptor expression in patients with advanced triple-negative metastatic breast cancer treated with sacituzumab govitecan: A French multicentre retrospective study
    Arnedos, M.
    Segier, B.
    Vincent, N.
    Robert, M.
    Grinda, T.
    Grellety, T.
    Deluche, E.
    Lehmann-Che, J.
    Jacot, W.
    Heymann, M-F.
    Lusque, A.
    Brunet, M.
    Teixeira, L.
    Guiu, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S384 - S384
  • [26] Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple-negative breast cancer
    Guiu, S.
    Charon-Barra, C.
    Mollevi, C.
    Boissiere, F.
    Crapez, E.
    Chartron, E.
    Lamy, P-J
    Gutowski, M.
    Bourgier, C.
    Romieu, G.
    Simony-Lafontainc, J.
    Jacot, W.
    CANCER RESEARCH, 2017, 77
  • [27] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Zhang, Minghui
    Zhang, Xiaosan
    Zhao, Shu
    Wang, Yan
    Di, Wenyu
    Zhao, Gangling
    Yang, Maopeng
    Zhang, Qingyuan
    TARGETED ONCOLOGY, 2014, 9 (04) : 349 - 357
  • [28] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Minghui Zhang
    Xiaosan Zhang
    Shu Zhao
    Yan Wang
    Wenyu Di
    Gangling Zhao
    Maopeng Yang
    Qingyuan Zhang
    Targeted Oncology, 2014, 9 : 349 - 357
  • [29] Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?
    Zaborowski, Matthew
    Pearson, Antonia
    Sioson, Loretta
    Gill, Anthony J.
    Ahadi, Mahsa S.
    PATHOLOGY, 2019, 51 (03) : 327 - 329
  • [30] Navigating the androgen receptor landscape in triple-negative breast cancer
    Sridhar, Nithya
    Ueno, Naoto T.
    LANCET ONCOLOGY, 2025, 26 (03): : 271 - 272
12345